Stock listing

NASDAQ:PPCO Penwest Pharmaceuticals Co Stock

Follow Penwest Pharmaceuticals Co into a list and get an email when it puts out news.

Last close · NASDAQ:PPCO

$4.99 USD

Close on Nov 4, 2010 · No longer trades

Jan 4, 1999 to last close -22.5% · monthly closes, Jan 4, 1999 – Nov 4, 2010
Lowest – highest close
$0.37 – $24.89 USDSince Jan 4, 1999 · lowest Nov 21, 2008 · highest Jul 28, 2003

Delisted NASDAQ:PPCO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:PPCO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Penwest Pharmaceuticals Co on 6ix

Decks
8 decks · latest Jun 14, 2010

Decks

DeckKindSlidesDate
Proxy Contest (June 2010)Proxy contest43 slidesJun 14, 2010
Proxy Contest (June 2010)Proxy contest25 slidesJun 4, 2010
Proxy Contest (June 2010)Proxy contest43 slidesJun 3, 2010
Proxy Contest (June 2009)Proxy contest34 slidesJun 5, 2009
Proxy Contest (May 2009)Proxy contest29 slidesMay 27, 2009
Proxy Contest (May 2009)Proxy contest32 slidesMay 22, 2009
Proxy Contest (May 2009)Proxy contest32 slidesMay 20, 2009
Investor Presentation (December 2008)Investor deck17 slidesDec 4, 2008

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anne VanLent
Other companies: Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Novelion Therapeutics Inc (Director · Nov 29, 2016 – Dec 22, 2016 · Past); Traws Pharma, Inc. (Director · Jul 24, 2013 – Jun 15, 2015 · Past); Vaxart, Inc. (Director · May 1, 2013 – Jun 12, 2019 · Past); Aegerion Pharmaceuticals Inc (Director · Apr 26, 2013 – Nov 29, 2016 · Past); Ocera Therapeutics Inc (Director · Apr 1, 2011 – Dec 11, 2017 · Past); Integra LifeSciences Holdings Corporation (Director · May 17, 2006 – May 17, 2012 · Past); Barrier Therapeutics Inc (Exec VP & CFO · Mar 31, 2006 – Mar 14, 2008 · Past)
Director · Jan 3, 2006 – Nov 4, 2010 · Past
Jennifer Good
Other companies: Rhythm Pharmaceuticals, Inc. (Director · Since at least Jun 19, 2019); Trevi Therapeutics, Inc. (President and Chief Executive Officer · Since at least May 7, 2019); Juniper Pharmaceuticals Inc (Director · Sep 7, 2017 – Aug 14, 2018 · Past)
President & CEO · Apr 28, 2010 – Nov 4, 2010 · Past
Saiid Zarrabian
Other companies: TuHURA Biosciences, Inc. (Head of Strategic Partnerships, Director · Jul 7, 2017 – Dec 6, 2021 · Past); La Jolla Pharmaceutical Co (Director · Jan 19, 2012 – May 14, 2015 · Past)
Director · Jun 30, 2010 – Sep 20, 2010 · Past
Benjamin L Palleiko
Other companies: KalVista Pharmaceuticals, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Nov 21, 2016)
SVP, Corporate Dev. & CFO · Jun 19, 2006 – Jun 18, 2008 · Past
Christophe Bianchi
Other companies: Millennium Pharmaceuticals Inc (Executive Vice President · Feb 1, 2006 – May 14, 2008 · Past)
Director · Jun 21, 2007 – Jan 4, 2010 · Past
Paul E Freiman
Other companies: Neurobiological Technologies Inc (President and CEO, Director · Sep 19, 2006 – May 30, 2008 · Past)
Director · Jan 3, 2006 – Jan 4, 2010 · Past
Peter F Drake
Other companies: Direct Markets Holdings Corp (Director · Oct 15, 2007 – May 6, 2011 · Past)
Director · Jan 3, 2006 – Sep 20, 2010 · Past
Amale HawiSVP, Pharmaceutical Dev. · Apr 25, 2007 – Nov 4, 2010 · Past
Anand BaichwalSVP Licensing & BD · Feb 3, 2006 – Nov 4, 2010 · Past
John G LemkeyDirector · Jun 30, 2010 – Jun 30, 2010 · Past
All 12 people
PersonSeat
Paul F HayesVP, Strategic Marketing · Apr 11, 2007 – Mar 5, 2009 · Past
Robert HennesseyDirector · Jan 3, 2006 – Jan 2, 2009 · Past

Open People

Log in to ask 6ix AI your own questions about Penwest Pharmaceuticals Co.